Director Jim Hollingshead to Succeed Shacey Petrovic as President and CEO, Effective June 1, 2022 Petrovic and Hollingshead to Continue as Members of Insulet’s Board of Directors ACTON, Mass. --(BUSINESS WIRE)--May 5, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global
ACTON, Mass. --(BUSINESS WIRE)--May 5, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended March 31, 2022 .
ACTON, Mass. --(BUSINESS WIRE)--May 2, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the release of its 2021 Sustainability Report.
ACTON, Mass. --(BUSINESS WIRE)--Apr. 27, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented new Omnipod® 5 Automated Insulin Delivery (AID) System study results in type 2
ACTON, Mass. --(BUSINESS WIRE)--Apr. 7, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the first quarter of 2022 on May 5,
Represents 6th Consecutive Year of Over 20% Revenue Growth; Annual Revenue Surpasses $1 Billion Omnipod 5 Automated Insulin Delivery System Receives U.S. FDA Clearance ACTON, Mass. --(BUSINESS WIRE)--Feb. 23, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in
ACTON, Mass. --(BUSINESS WIRE)--Feb. 17, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, is celebrating representation and inclusion for the diabetes community through an activation in
ACTON, Mass. --(BUSINESS WIRE)--Feb. 16, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at two upcoming investor conferences: The Raymond
ACTON, Mass. --(BUSINESS WIRE)--Feb. 7, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Elizabeth “Bess” Weatherman has been appointed to the Company’s Board of
ACTON, Mass. --(BUSINESS WIRE)--Jan. 12, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the fourth quarter and full year of
ACTON, Mass. --(BUSINESS WIRE)--Nov. 24, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at the virtual 45 th Nasdaq Investor Conference on Friday,
ACTON, Mass. --(BUSINESS WIRE)--Nov. 4, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended September 30, 2021 .
ACTON, Mass. --(BUSINESS WIRE)--Nov. 1, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced various activities to recognize Diabetes Awareness Month and World Diabetes Day
ACTON, Mass. --(BUSINESS WIRE)--Oct. 18, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Luciana Borio , M.D., has been appointed to the Company’s Board of Directors.
